Pure Global
NCT06139913

Aerobic Exercise on Fitness Score and Blood Glucose Level in Adolescents Girls With Diabetes Mellitus

Effect of Fat Burning Zone of Aerobic Exercise on Fitness Score and Blood Glucose Level in Adolescents Girls With Diabetes Mellitus
MTI University·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes Mellitus
Drug/Device/Intervention
aerobic exercise
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
MTI University
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Mar 15, 2023
End date
Sep 17, 2023
Enrollment
40 participants
Primary outcome

Fitness score:,Fasting blood samples, post prandial and HbA1c:,Estradiol blood test

Summary

In adolescent diabetic girls, a correct life style, including diet and physical activity, is
 part of a correct intervention protocol. Thus, the aim of this study was to evaluate the
 effects of aerobic training intervention, based on heart rate at glycemic level , on clinical
 and physiological parameters in adolescent girls with type 1 diabetes forty type1 DM girls
 will randomly assigned to an intervention (study group ) or control group. The study group
 will perform a supervised aerobic exercise training based on heart rate whereas control group
 maintained their usual lifestyle. Anthropometric fitness score measures, blood analysis will
 assess at baseline and after intervention.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06139913
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06139913 through Pure Global AI's free database. This phase not specified trial is sponsored by MTI University and is currently Completed. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.